MY194758A - Stable liquid pharmaceutical formulation - Google Patents
Stable liquid pharmaceutical formulationInfo
- Publication number
- MY194758A MY194758A MYPI2018704138A MYPI2018704138A MY194758A MY 194758 A MY194758 A MY 194758A MY PI2018704138 A MYPI2018704138 A MY PI2018704138A MY PI2018704138 A MYPI2018704138 A MY PI2018704138A MY 194758 A MY194758 A MY 194758A
- Authority
- MY
- Malaysia
- Prior art keywords
- pharmaceutical formulation
- liquid pharmaceutical
- stable liquid
- antibody
- present
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The present invention provides a stable liquid pharmaceutical formulation containing:an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170006855 | 2016-06-30 | ||
PCT/KR2017/006855 WO2018004260A1 (en) | 2016-06-30 | 2017-06-28 | Stable liquid pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MY194758A true MY194758A (en) | 2022-12-15 |
Family
ID=57850975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2018704138A MY194758A (en) | 2016-06-30 | 2017-06-28 | Stable liquid pharmaceutical formulation |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY194758A (en) |
-
2017
- 2017-06-28 MY MYPI2018704138A patent/MY194758A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20180125B1 (en) | Stable liquid pharmaceutical preparation | |
AU2014318696B2 (en) | Liquid protein formulations containing organophosphates | |
MX2018003306A (en) | Stable anti-pd-1 antibody pharmaceutical preparation and application thereof in medicine. | |
PH12017500844A1 (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
MX2017010400A (en) | Stable liquid formulation for monoclonal antibodies. | |
MX370207B (en) | Stabilized antibody compositions. | |
MX2017004306A (en) | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents. | |
ZA201908610B (en) | Il-15 protein complex pharmaceutical composition and uses thereof | |
EP4249060A3 (en) | Liquid pharmaceutical composition of adalimumab | |
CR20220322A (en) | Anti-pd-l1 antibody formulations | |
MY194758A (en) | Stable liquid pharmaceutical formulation | |
WO2022045857A3 (en) | Stable pharmaceutical preparation | |
SA520420369B1 (en) | A pharmaceutical dry powder composition for inhalation comprising a thyroid hormone | |
TH1701002015A (en) | Vaccine composition with reduced foaming |